DU125530

DB16040InvestigationalSmall molecule

DU125530 is under investigation in clinical trial NCT01119430 (Fluoxetine Versus Fluoxetine Plus DU125530 in Major Depressive Disorder).

Mechanism: Pharmacologically active on 5-hydroxytryptamine receptor 1A
Curator reviewed
Formula / weight: C₂₃H₂₆ClN₃O₅S · 491.99 g/mol (avg)
Code names: DU-125530

Resolves to

Compound

Structure

InChIKeyLYXKFNHUJJDTIA-UHFFFAOYSA-NSMILESClC1=CC(N2CCN(CCCCN3C(=O)C4=C(C=CC=C4)S3(=O)=O)CC2)=C2OCCOC2=C1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with DU125530, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.